I’m a biotech sales analyst in Boston using IQVIA Xponent and Veeva to size TAM and track share, and I’m exploring a move into device or diagnostics sales in 2025. For hiring managers and reps, which metrics or experiences convert best on a resume — market mapping, HCP segmentation, win/loss analysis, or forecast accuracy — and how should I quantify impact (for example, territory whitespace modeling adding 12% incremental opportunity)?
In health system and payer buyers, “assistant” beat “copilot” whenever the workflow touched PHI or scheduling — legal hears “copilot” and yanks the parking brake. When we kept “copilot” but added a line like “decision support, not decision maker” and “human-in-the-loop,” demo requests recovered and sometimes beat “assistant” by about 8–10%. If you’re selling into compliance-heavy teams, A/B a risk-reduction subhead before swapping the noun.
Quantify ‘demo lift’: Xponent segmentation → 30 new HCP targets, +18% demos; tie to quota; add Veeva cycle-time cuts.
What got me calls moving from analytics to diagnostics was spelling out pilot‑to‑contract conversion with time‑to‑first order; e.g., Xponent‑segmented 50 HCPs → 10 net‑new accounts in 90 days, 62% trial→contract, +$550k pipeline, tied to 38% of quarterly quota. I’m with @t_woodland1990 on cycle time, but forecast accuracy only popped when I linked it to fewer backorders/OTIF risk — can you frame yours that way?
Building on @h_marlowe82, what got me calls was proving I could navigate committees: quantify a ‘VAC approval rate’ and demo‑to‑reorder days, not just TAM math. Example: mapped 4 IDNs, built 2 clinical champions per site, earned 3 VAC approvals in 90 days, $480K year‑one revenue; if you don’t have approvals yet, use ‘stakeholders engaged per win’ and distributor pull‑through as proxies. Think pit crew, not lap times.